Roxane Laboratories, Inc. Announces the Launch of Galantamine Hydrobromide Oral Solution
Published: Aug 25, 2009
COLUMBUS, Ohio, Aug. 24 /PRNewswire/ -- Roxane Laboratories, Inc. announced today the availability of Galantamine Hyrdrobromide Oral Solution, 4mg/mL as of August 14, 2009. The product, indicated for mild to moderate dementia related to Alzheimer's disease, is available for immediate shipment to wholesalers and pharmacies nationwide. Currently this product is available as a generic from Roxane Laboratories.